超分子免疫调节水凝胶剂以持久内源性免疫增强 CAR-T 疗法实现实体瘤清除

Supramolecular immunomodulatory hydrogelator potentiates CAR-T therapy with long-lasting endogenous immunity toward solid tumor eradication.

αvβ3 CAR-T 细胞同时靶向肿瘤和转移灶，在黑色素瘤和三阴性乳腺癌的临床前模型中产生高度有效的控制

αvβ3 CAR-T Cells Simultaneously Targeting Tumor and Metastases Produce Highly Effective Control in Preclinical Models of Melanoma and Triple-Negative

淋巴毒素 β 受体在实体瘤免疫及治疗靶向中的多效性与多细胞作用

Pleiotropic and multicellular roles of lymphotoxin beta receptor in solid tumor immunity and therapeutic targeting.

基于 CAR-T/NK/M 的肿瘤联合治疗：全面综述

CAR-T/NK/M-based combination therapies in cancer: A comprehensive review.

通过新型嵌合抗原受体 (CAR)-T 细胞平台靶向 TGF-β 对接受体糖蛋白 A 重复序列主要蛋白 (GARP) 治疗胶质母细胞瘤

Targeting TGFβ docking receptor glycoprotein A repetitions predominant (GARP) via novel chimeric antigen receptor (CAR)-T cell platform to treat gliob

GARP-LTGF 在 GBM 的发生和预后中发挥关键作用，靶向 GARP 的 CAR-T 治疗在小鼠原位 GBM 模型中显示出有前景的疗效和安全性。

靶向 HER2 阳性实体瘤的纳米抗体 CAR-T 细胞临床前开发与筛选

Preclinical development and selection of nanobody-based CAR-T cells targeting HER2-positive solid tumors.

靶向癌症干细胞的 CAR 免疫疗法：生物学、证据和未来方向

Targeting cancer stem cells with CAR-based immunotherapy: biology, evidence, and future directions.

闭环声热遗传学调控 CAR-T 细胞用于节拍式脑肿瘤治疗

Closed-loop sonothermogenetic control of CAR T cells for metronomic brain cancer therapy.

靶向 PD-L1 同时攻击肿瘤细胞与免疫抑制细胞的实体瘤 CAR-T 细胞治疗

Solid cancer-directed CAR T cell therapy that attacks both tumor and immunosuppressive cells via targeting PD-L1.

弥漫性内生型脑桥胶质瘤的当前免疫治疗策略

Current immunotherapeutic approaches to diffuse intrinsic pontine glioma.